Technical Analysis for ZURA - Zura Bio Limited
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Doji - Bullish? | Reversal | 0.00% | |
Fell Below 20 DMA | Bearish | -0.45% | |
20 DMA Support | Bullish | -5.40% | |
MACD Bearish Signal Line Cross | Bearish | -2.23% | |
20 DMA Support | Bullish | -2.23% | |
Wide Bands | Range Expansion | -2.23% | |
Wide Bands | Range Expansion | -4.99% | |
Pocket Pivot | Bullish Swing Setup | -7.59% | |
Wide Bands | Range Expansion | -7.59% | |
NR7 | Range Contraction | -4.78% |
Alert | Time |
---|---|
Possible NR7 | about 20 hours ago |
Down 3% | about 22 hours ago |
Fell Below Previous Day's Low | about 24 hours ago |
Down 2 % | about 24 hours ago |
Down 1% | about 24 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: Unknown
Zura is a clinical-stage biotechnology company advancing immunology assets into Phase 2 development programs, including ZB-168 and torudokimab. ZB-168 is an anti IL7R α inhibitor that has the potential to impact diseases driven by IL7 and TSLP biological pathways. Zura aims to develop a portfolio of therapeutic indications for ZB-168 which build on existing Phase 1b data in Type 1 Diabetes demonstrating a favorable safety profile and strong biological rationale. Torudokimab is a fully human, high affinity monoclonal antibody that neutralizes IL33 and is currently at the Phase 2 clinical development stage.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Immunology Diabetes Monoclonal Antibody Antibody
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Immunology Diabetes Monoclonal Antibody Antibody
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 6.35 |
52 Week Low | 2.0 |
Average Volume | 470,394 |
200-Day Moving Average | 3.85 |
50-Day Moving Average | 4.15 |
20-Day Moving Average | 4.46 |
10-Day Moving Average | 4.62 |
Average True Range | 0.29 |
RSI (14) | 49.75 |
ADX | 18.98 |
+DI | 26.50 |
-DI | 21.20 |
Chandelier Exit (Long, 3 ATRs) | 4.21 |
Chandelier Exit (Short, 3 ATRs) | 4.67 |
Upper Bollinger Bands | 5.10 |
Lower Bollinger Band | 3.82 |
Percent B (%b) | 0.44 |
BandWidth | 28.69 |
MACD Line | 0.12 |
MACD Signal Line | 0.17 |
MACD Histogram | -0.0436 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 4.62 | ||||
Resistance 3 (R3) | 4.61 | 4.51 | 4.58 | ||
Resistance 2 (R2) | 4.51 | 4.45 | 4.52 | 4.57 | |
Resistance 1 (R1) | 4.45 | 4.41 | 4.48 | 4.46 | 4.55 |
Pivot Point | 4.35 | 4.35 | 4.37 | 4.36 | 4.35 |
Support 1 (S1) | 4.29 | 4.29 | 4.32 | 4.30 | 4.21 |
Support 2 (S2) | 4.19 | 4.25 | 4.20 | 4.19 | |
Support 3 (S3) | 4.13 | 4.19 | 4.18 | ||
Support 4 (S4) | 4.14 |